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Terminal deoxynucleotidyl transferase (TdT; EC 2.7.7.31) adds nucle-
otides to DNA ends generated during V(D)J recombination that are
subsequently processed by proteins involved in general double-
strand break (DSB) repair pathways. We report an association be-
tween TdT and a 55-kDa protein in lymphoid cells. This protein,
identified as hPso4, is a homolog of the protein encoded by the
PS04PRP19 gene in Saccharomyces cerevisiae that has pleiotropic
functions in DNA recombination and error-prone repair. Purified
hPso4 binds double-stranded DNA in a sequence-nonspecific manner
but does not bind single-stranded DNA. hPso4 protein is induced 15-
to 30-fold in cells by  radiation and chemical mutagens but not by UV
treatment. Loss of hPso4 expression induced by siRNA results in
accumulation of DSBs, apoptosis, and decreased cell survival after
DNA damage. We conclude that hPso4 plays a major and previously
undefined role in mammalian DNA DSB repair.
double-strand breaks  end joining
Cells encounter genomic lesions in the form of double-strandbreaks (DSBs). In mammalian cells, DSB repair (DSBR) is
mediated either by the error-free homologous recombination (HR)
or the more predominant error-prone nonhomologous end joining
(NHEJ) pathways (1). Agents that induce other types of DNA
lesions, such as DNA interstrand crosslinks and adducts that
proceed via DSB intermediates, are thought to invoke more than
one type of DNA repair, including HR, nucleotide excision repair,
and, to a lesser extent, the NHEJ pathway (2). The NHEJ repair
proteins Ku7086, DNA PKcs, and Xrcc4ligase IV are ubiqui-
tously expressed and function both in generalized DSBR and in the
repair of ends generated during V(D)J recombination, a pro-
grammed gene rearrangement process that leads to the assembly of
Ig and T cell receptors (3). Although these proteins seem sufficient
for end joining in vitro, recent studies suggest the requirement of
additional unknown factors for end joining in vivo (3, 4). One such
recently identified human protein is artemis, mutations in which
result in ionizing radiation sensitivity and severe combined immu-
nodeficiency (5). Artemis protein has an inherent 5 to 3 single-
strand specific exonuclease activity. However, its association with
and phosphorylation by DNA PKcs alter its activity to enable
endonucleolytic processing of overhangs and cleavage of hairpin
substrates such as those generated during V(D)J recombination (6).
Terminal deoxynucleotidyl transferase (TdT; EC 2.7.7.31), a
template-independent DNA polymerase, is unique in its expression
and function, because it is expressed only in lymphoid cells under-
going V(D)J recombination (3) and has the ability to add nucleo-
tides to the recombining V, (D), and J coding ends, thereby
promoting antibody and receptor diversity (7). Our earlier studies
revealed the association of TdT with the NHEJ protein Ku via the
TdT BRCA1 C terminus (BRCT) region (8). Experiments per-
formed with Ku86-deficient mice and cell lines have indeed dem-
onstrated an absolute requirement of Ku86 for TdT-mediated
nucleotide insertions at the V(D)J recombination intermediates (9,
10). The presence of TdT and Ku86 in etoposide-induced nuclear
foci (8), the assembly of DNA repair proteins in similar foci after
radiation-induced DNA damage (11), and the association of TdT
with a large protein complex in thymic nuclear matrix (12) all
suggest that TdT may interact with proteins in addition to Ku that
are necessary for DSBR.
Our objective was to identify proteins associating with TdT that
might participate at DSBs generated during V(D)J recombination
andor DNA repair. This approach has resulted in the identification
of hPso4, a homolog of the ScPSO4PRP19 gene product that
functions in DNA repair and recombination (13). Our results
suggest that hPso4 has a major previously undefined role in
mammalian DNA repair, because its induced deficiency results in
apoptosis and decreased clonogenic survival after DNA damage.
Materials and Methods
Cell Lines. All cell lines were obtained from American Type Culture
Collection. The origin of the cell lines is as follows: HL60, human
leukemia; HeLa, cervical carcinoma; Jurkat, T cell lymphoma;
Molt4, preT lymphoma; Nalm6, preB lymphoma; PC12, rat neu-
ronal cells; SV80, human fibroblast; U937, human monocyte; and
MRC5, normal human fibroblast. Cells were -irradiated by using
a Mark I Cs137 or UV-irradiated at a dose of 15 Jm2; drugs used
were cisplatin (100 gml), bleomycin (100 gml), mitomycin C
(5–50 gml), and etoposide (5–50 M).
GST Pull-Down. The BRCT domain, N-terminal region of TdT, and
TdT were PCR amplified and cloned into pGex-4T-1 (Pharmacia).
The expression of the GST-TdT fusion proteins was induced by
isopropyl -D-thiogalactoside. The induced bacterial cell lysate was
incubated in buffer containing 150500 mM NaCl; 50 mM Tris, pH
7.5; 0.3% Triton X-100; 1 mM EDTA; and 1 protease inhibitor
(Roche Molecular Biochemicals), with glutathione Sepharose
beads for 45 min. The beads were washed (three times), incubated
with cell extracts for 2 h, washed again (three times), resuspended
in 1.5 loading buffer, electrophoresed on SDS10% PAGE gels,
and stained with Coomassie blue.
Peptide Sequencing. The 55- and 110-kDa polypeptides were excised
from Coomassie-stained gels and sequenced by mass spectrometry
at the Burroughs Wellcome Facility, Research Triangle Park, NC.
The sequence of the 44-kDa TdT was obtained by using the Edman
method and starts at STNTGPPKT.
Cloning of Human Pso4. PSO4 cDNA was amplified from Molt-4
polyA mRNA with the primers 5-ATGGGATCCATGTC-
CCTAATCTGCTCCATCTCT and oligo(dT) (Stratagene). The
sequence matched the previously reported sequence for hNMP200
(gi:17391460).
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Antibodies. Polyclonal antibodies were raised to the purified GST-
Pso4 and affinity purified. Anti-TdT and anti-polyHistidine (His)
antibodies were described previously (8). Anti-Cdc5 antibodies
were a gift from Peter Groenen (University of Leuven, Leuven,
Belgium).
Coimmunoprecipitation Assays. Lysates were processed as described
(8). For in vitro binding assays, 1 g of either purified TdT or hPso4
was mixed in 0.5 ml of binding buffer and processed as described (8).
Purification of Recombinant hPso4. A baculovirus expression con-
struct of human His-Pso4 was generated by using the pFast Bac
method (GIBCO-BRL). Recombinant protein was purified from
Sf9 cultures and processed per manufacturer’s protocol by using
Talon affinity beads (Clontech). The fractions were analyzed by
SDSPAGE and Coomassie staining. Fractions containing the
purified protein were pooled and dialyzed against 50 mM Tris, pH
7.510% glycerol0.1 mM NaCl1 mM DTT, and aliquots were
stored at –80°C.
Gel Mobility-Shift Assays. Radiolabeled single-stranded (ss)DNA
substrate was made by 5 end labeling with T4 polynucleotide kinase
and [-32P]ATP. KM1 (5-GATCTGGCCTGTCTTACACAGT-
GCTACAGACTGGAACAAAAACCCTGCAG); double-
stranded (ds)DNA was made by annealing the labeled KM1 to
BO50 (5-GCAGGGTTTTTGTTCCAGTCTGTAGCACT-
GTGTAAGACAGGCCAGATCCT). DNA was incubated with
varying protein concentrations for 10 min at room temperature in
a 10-l reaction buffer (20 mM Tris, pH 7.550 mM NaCl1 mM
DTT1 mM MgCl20.1 mg/ml BSA). Samples were electropho-
resed for 60 min at 10 Vcm on a 3.5% polyacrylamide gel in 1
Tris-borate–EDTA buffer.
Small Interfering RNA (siRNA) Transfections. siRNAs were chemically
synthesized and ion exchange-HPLC purified to 99.5% purity
(Xeragon, Germantown, MD) and are as follows: hPso4 5-ACC-
ACAGGCUGGCCUCAUUTT-3, 5-AAUGAGGCCAGCCU-
GUGGUTT-3. Control nonsilencing siRNA was obtained from
Xeragon. The annealed ds siRNA was resuspended in buffer (100
mM potassium acetate30 mM HepesKOH2 mM magnesium
acetate, pH 7.4) to obtain a 20 M solution.
In Situ Labeling of DNA Strand Breaks. siRNA (105) transfected HeLa
cells were -irradiated (15 Gy) and fixed after 3 h with 1%
paraformaldehyde. DNA strand breaks were labeled with Br-dUTP
by using TdT, stained with anti-BrdUrd-FITC (BioVision, Moun-
tain View, CA), and detected by flow cytometry (14).
Cell Death ELISA. Assays were set up per manufacturer’s instructions
with minor modifications (Roche Molecular Biochemicals). Twen-
ty-four hours before transfection, cells were split to 1  105 cells per
well in a six-well plate and transfected with 2 g of siRNA by using
oligofectamine (Invitrogen). Transfection medium was removed
18–24 h later, and etoposide (5–50 M) or Miotmycin C (10–50
gml) was added in fresh medium for 1 h. After removal of drug,
cells were incubated in fresh medium and harvested after 24 h.
Clonogenic Survival Assays. HeLa cells were transfected with siR-
NAs as described above. After exposure to DNA-damaging agents,
cells were trypsinized, counted, and plated at a density of 200 cells
per 100-mm-diameter dish. Twelve to 15 days later, colonies were
fixed with 0.2% paraformaldehyde, stained with 0.1% crystal violet,
and counted.
Results
Association Between the BRCT Domain of TdT and a 55-kDa Protein.
The BRCT domain found in TdT is a protein–protein interaction
motif found in many DNA repair and cell cycle proteins (8). To
identify other proteins that might interact with TdT, we generated
GST-fusion expression constructs encoding the BRCT domain of
TdT alone, the N-terminal fragment of TdT containing the BRCT
domain but lacking the catalytic domain, or full-length TdT (Fig.
1A). Whole cell extracts prepared in buffers containing 500 mM
NaCl from Molt-4 and Nalm-6 lymphoid cells were incubated with
the GST-fusion proteins prebound to glutathione Sepharose beads.
Two proteins of 55 and 110 kDa were specifically isolated with all
three fusion proteins but not with GST alone (Fig. 1B, compare
lanes 2 and 6 to lanes 3–5 and 7–9). The interaction of TdT with the
two proteins was also observed at physiological salt concentration
(150 mM) and occurred in all cell lines examined, whereas the
interaction with the 110-kDa protein was restricted to lymphoid cell
lines (Fig. 1C, lanes 5–7). Because these interactions are present at
high salt concentration (500 mM NaCl), they represent the specific
interaction of each protein with the BRCT domain of TdT.
Fig. 1. Association of TdT with 55- and 110-kDa proteins. (A) Schematic repre-
sentation of TdT constructs. Full-length TdT (58 kDa) containing an N-terminal
BRCT domain, a DNA-binding domain (DBD), and a nucleotide-binding domain
(NBD); 44-kDa protein lacking the BRCT domain; 22-kDa protein lacking the DBD
and NBD domains; BRCT domain only. (B and C) Proteins were resolved on
SDS10% PAGE gels and visualized by Coomassie staining. (B) GST pull-down of
Molt-4 and Nalm-6 proteins binding to TdT constructs. Lane 1, molecular weight
markers; lanes 2–5, GST or GST-fusion proteins incubated with 500 g of Molt-4
cell extract; lanes 6–9, GST or GST-fusion proteins incubated with 500 g of
Nalm-6 cell extract; lane 10, purified TdT. (C) Binding of proteins from indicated
tumor cell lines to the GST-BRCT. Five hundred micrograms of extracts were
incubated with GST-BRCT protein in buffers containing 500 mM NaCl and 0.3%
Triton X-100. Lane 1, molecular weight markers; lane 2, GST-BRCT alone; lanes
3–10, whole cell extracts incubated with fusion protein.








Microsequencing and Characterization of the 55-kDa Protein. To
further characterize the TdT-interacting proteins, gel slices con-
taining the 55- and 110-kDa proteins were microsequenced. Mass
spectrometric analysis revealed the sequences of six polypeptides
from the 55-kDa protein (Fig. 2A). BLAST search of the protein
database demonstrated that one peptide fragment was identical to
a peptide encoded by a 200-bp human-expressed sequence tag.
RT-PCR from the Molt-4 cell line amplified a 1.6-kb DNA frag-
ment that encoded a protein that contained all of the six polypep-
tide fragments (Fig. 2A). Northern analysis showed ubiquitous
expression of the corresponding 2.4-kb mRNA in human multiple
tissue blots (Clontech) (Fig. 2B). A protein BLAST search revealed
38% sequence identity and 56% similarity with the ScPSO4PRP19
gene product, the highest degree of homology observed for the
55-kDa protein in yeast, and 80% homology with an uncharac-
terized 55-kDa protein from rodents and Drosophila (Fig. 8,
which is published as supporting information on the PNAS web site,
www.pnas.org). We therefore refer to this protein as hPso4. Do-
main analysis predicts similar protein architecture among plant,
yeast, rodent, and human proteins. The U box at the N terminus is
a modified RING finger domain present in a subset of ubiquitin
ligases such as RAD5 that has been hypothesized to have a role in
E2-binding and ubiquitination of the target protein in response to
DNA damage (15). The C terminus of hPso4 contains six successive
WD-40 or  transducin-like repeats (Fig. 2A), which are known to
form a structural interface for the assembly of multiprotein com-
plexes. hPso4 has also been identified as a component of the nuclear
matrix (NMP200) (16).
Peptide analysis of the 110-kDa protein revealed it to be a
previously identified cell division cycle protein, hCdc5 (17). West-
ern analysis showed ubiquitous expression of hCdc5 in most cell
lines (data not shown) in agreement with the hCdc5 mRNA
expression data from several adult tissues (17). However, hCdc5
was pulled down with TdT fusion proteins only in extracts from cell
lines expressing endogenous TdT and hPso4, whereas hPso4 asso-
ciated with TdT in all cell lysates tested. This result suggests that the
interaction between hCdc5 and TdT is indirect, possibly requiring
additional protein(s) present only in lymphoid cells.
Interaction of hPso4 with TdT in Vivo and in Vitro. To determine
whether the interaction between hPso4 and TdT is physiologically
relevant, we performed coimmunoprecipitation experiments in
lymphoid cell extracts. Whole cell extracts were prepared from
Molt-4 cells that contain endogenous TdT and hPso4. Lysates were
incubated with either rabbit preimmune serum, anti-hPso4, anti-
Fig. 2. Sequence and schematic representation of the 55-kDa protein. (A
Upper) Amino acid sequences of the hPso4 peptide fragments identified by mass
spectrometry are underlined. (Lower) Schematic representation of the hPso4
proteinshowingtheU-box location,Prp19homologyregion,andWD-40repeats.
(B) Northern analysis of hPSO4 mRNA in human multiple tissue blots (Clontech).
Fig. 3. Coimmunoprecipitation of TdT and hPso4. (A) Western blots of 50 g of
Molt-4 and Jurkat cell extracts by using affinity-purified rabbit polyclonal anti-
bodies raised to the GST-Pso4 fusion protein. (B) Immunoprecipitation of TdT
from200gofMolt-4extractbyusingpreimmuneserum,anti-hPso4,anti-hCdc5,
and anti-TdT antibodies. Immune complexes were probed by using anti-TdT
antibody. Lane 1 contains 60 g of Molt4 lysate. (C) Purification of recombinant
hPso4 from Sf9 cells. (Upper) Coomassie stain. Lane 1, molecular weight markers;
lane 2, input; lane 3, FT flow-through; lanes 4 and 5, wash; lanes 6–10, 100 mM
imidazole eluates. (Lower) Western blot by using anti-His antibodies. (D) Inter-
action of TdT and hPso4. Lane 1, purified TdT; lane 2, purified TdT with anti-His
antibody; 58-kDa TdT immunoprecipitated from a preformed complex of 44-kDa
TdT, 58-kDa TdT, and His-hPso4 with anti-TdT (lane 3) or anti-His antibody
(lane 4).
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hCdc5, or anti-TdT antibodies. The immunoprecipitates were
tested for the presence of TdT. Anti-TdT and anti-hPso4 antibodies
immunoprecipitated the 58-kDa TdT, whereas the preimmune
serum and anti-hCdc5 did not (Fig. 3B). Anti-hPso4 and anti-hCdc5
antibodies also immunoprecipitated a small amount of the 44-kDa
TdT present in the cell lysate (Fig. 3B, lanes 1, 3, and 4). Coim-
munoprecipitations were performed at physiological salt concen-
tration (150 mM NaCl), a condition permissive for DNA–protein
interactions. Because the 44-kDa TdT, 58-kDa TdT, and hCdc5
bind DNA, their presence in hPso4 and hCdc5 antibody pull-downs
could be due to indirect interactions mediated by DNA.
To eliminate such potential indirect associations, coimmuno-
precipitations were performed with purified proteins. To obtain
purified hPso4, a baculovirus construct was generated with a
six-His tag at the N terminus of hPso4. The protein was purified
to 99% homogeneity from Sf9 insect cells on a Talon affinity
column (Fig. 3C Upper, lanes 7–10). Anti-His antibodies recon-
firmed the purification of hPso4 (Fig. 3C Lower, lanes 7–10).
Purification of TdT has been reported (8). Coimmunoprecipi-
tation assays were performed with a mixture of purified proteins
containing the 58-kDa TdT, 44-kDa TdT, and His-hPso4 (Fig.
3D). Anti-His antibodies coimmunoprecipitated only the 58-kDa
TdT and not the 44-kDa TdT from the mixture (Fig. 3D;
compare lanes 2, 3, and 4), indicating that only the 58-kDa TdT
physically associates with hPso4. Because the 44-kDa TdT lacks
the BRCT domain of TdT (Fig. 1 A), it appears that the BRCT
domain is essential for the interaction between TdT and hPso4.
DNA-Binding Properties of hPso4. TdT catalyzes nucleotide polymer-
ization at DNA ends. We therefore tested whether purified hPso4
binds directly to DNA by using gel mobility-shift assays and
radiolabeled ss- and dsDNA substrates. hPso4 did not bind 32P-
labeled 50-mer ss oligo (5 nM) over a range of protein concentra-
tions (90–540 nM) (Fig. 4A, lanes 2–6). In contrast, a single
high-mobility band was observed on incubation of increasing con-
centrations (90–540 nM) of hPso4 with 32P-labeled 50-bp dsDNA
(5 nM) (Fig. 4B, lanes 2–6). hPso4 also readily bound plasmid DNA
substrates, suggesting a lack of sequence specificity. DNA–protein
complexes were also observed with closed circular plasmid DNA,
indicating that hPso4 does not require free ends to bind DNA (Fig.
4C, lanes 2–5).
Up-Regulation of hPso4 After DNA Damage. In view of the ability of
hPso4 to bind dsDNA in a sequence-nonspecific manner and the
role of ScPSO4 gene product in DNA end joining (18), we examined
the role of hPso4 in mammalian DNA repair by exposing cells to
genotoxic agents that create lesions in the DNA. The normal
human fibroblast cell line, MRC5, was -irradiated, and whole cell
extracts were prepared at different times postirradiation. Western
analysis demonstrated a 17- to 30-fold increase in hPso4 protein
levels at 1–2 h, followed by a rapid decrease by 4 h (Fig. 5A, lanes
3–6). The increase in hPso4 expression was concurrent with the
phosphorylation of p53 at Ser-15, an event that signals DNA
damage (Fig. 5A Middle). Levels of the NHEJ protein Ku86 were
not altered after  irradiation (Fig. 5A Bottom). A similar induction
of hPso4 levels after irradiation exposure was also observed in two
unrelated fibroblast and lymphoid cell lines (data not shown).
HPso4 was also up-regulated in response to the antitumor
DSB-inducing agent bleomycin (Fig. 5B), whereas the DNA
crosslinking agents cisplatin (Fig. 5C) and mitomycin C (Fig. 5D)
caused biphasic induction in hPso4 levels. The initial 2.9- to 3.5-fold
induction at 1 h could be due to the crosslinks that are first formed
in the DNA, whereas the 15-fold increases at 4 and 6 h, respectively,
coincide with the maximal intensity of p53 Ser-15 phosphorylation,
suggesting the appearance of DSBs at these time points. In contrast,
cells treated with UV radiation (15 Jm2) did not demonstrate
induction (Fig. 5E).
Effects of Down-Regulation of hPso4 by siRNA on DSBs, Apoptosis, and
Cell Survival After DNA Damage. To determine whether the induc-
tion of hPso4 is essential for DNA repair in vivo, we analyzed the
response of hPso4-deficient cells to DNA damage. To this end, we
synthesized siRNAs directed to an internal region of hPSO4 cDNA.
MRC5 cell lines transfected with hPso4 siRNA but not the control
siRNA specifically down-regulate the levels of hPso4 protein and
prevent further induction after 12 Gy of  irradiation (Fig. 6A).
Although the overall protein loading is not uniform, as judged by
the amount seen on Ku Western blots, the protein levels at 0, 1, and
2 h are internally comparable between the control and hPso4
siRNA transfected cells. Similarly, HeLa cells transfected with
hPso4 siRNA demonstrate significant reduction in hPso4 protein
levels 24–48 h posttransfection (Fig. 6B).
To test whether hPso4 is necessary for the repair of DSBs, cells
transfected with control or hPso4 siRNA for 24 h were then
exposed to 15 Gy  irradiation followed by repair incubation for
3 h and fixed (19). DSBs were labeled in situ with Br-dUTP by
using TdT, stained with anti-BrdUrd-FITC, and detected by flow
cytometry (14). Cells transfected with hPso4 siRNA demon-
strated 100-fold increase in Br-dUTP incorporation after
DNA damage (Fig. 6C) in two independent transfections, in-
dicative of the presence of unrepaired strand breaks, whereas the
anti-BrdUrd-FITC staining of irradiation-exposed control
siRNA cells is near the levels seen in unirradiated cells, sug-
gesting the repair of genotoxic lesions.
To determine whether the increase in DSBs in hPso4 siRNA
transfected cells correlated with a decrease in cell survival, cells
transfected with the siRNAs were treated with etoposide (10–50
M) or mitomycin C (5–50 gml) and assayed for apoptosis after
Fig. 4. Binding of hPso4 to DNA radiolabeled DNA was incubated with purified hPso4 protein. The reaction products were analyzed on native polyacrylamide gels
followed by autoradiography (A and B) or 0.7% agarose gel stained with ethidium bromide (C). (A) hPso4 binding to ssDNA. Lane 1, 32P-labeled 50-mer ssDNA (5 nM)
and increasing amounts of hPso4 (lanes 2–6, 90–540 nM). (B) hPso4 binding to dsDNA; 5 nM 32P-labeled 50 bp of duplex DNA (lane 1) and increasing amounts of hPso4
(lanes 2–6, 90–540 nM). (C) hPso4 binding to circular plasmid DNA; 12 nM pBKS dsDNA (lane 1) and increasing amounts of hPso4 (lanes 2–5, 0.4–0.7 m).








24 h. hPso4-deficient cells underwent rapid dose-dependent apo-
ptotic cell death with both DNA-damaging agents, whereas the
parental and the control siRNA transfected cells did not (Fig. 7 A
and B). Clonogenic survival assays also showed a significant de-
crease (P  0.05) in cell survival of the hPso4-deficient cells, with
increasing doses of both  irradiation (Fig. 7 C and D) and etoposide
(data not shown) in comparison to the parental cells or the control
siRNA transfected cells, strongly suggesting defective DNA repair
in the hPso4-deficient cells.
Discussion
We have identified a human homolog of the yeast Pso4 protein
through its association with the lymphoid-specific polymerase,
TdT. The hPso4 protein is ubiquitously expressed, and its
expression is increased in response to  irradiation, radiomimetic
drugs, and DNA crosslinking agents. Furthermore, decreased
expression of the protein induced by siRNA before and after
DNA damage leads to accumulation of DSBs, marked enhance-
ment of apoptosis, and decreased clonogenic survival of HeLa
cells expressing endogenous hPso4 protein. These observations
strongly support the hypothesis that hPso4 plays an important
role in DNA repair processes that result from the induction of
DSBs.
Studies in yeast have led to the identification of nine distinct
structurally unrelated genes important for resistance to the lethal
effects of psoralen-UVA induced DNA crosslinks. Of these ‘‘PSO’’
genes, seven have been demonstrated to have a role in DNA repair.
Notably, in pso2-1snm1 and pso4-1 mutants, accumulation of
DSBs was found by sucrose gradient analysis after interstrand
crosslink-induced DNA damage, implicating their gene products in
the processing andor rejoining of DNA ends (18, 20, 21). Genetic
interactions have also been observed among yeast pso mutants,
suggesting that their gene products may functionally interact to
repair crosslink-induced DNA damage (18, 20).
Members of the mammalian Pso2Snm1 family have also been
documented to play important roles in DNA repair. Mouse
snm1() embryonic stem cell lines and snm1 knockout mice
are sensitive to mitomycin C (22). hSnm1 is a human ScPSO2
SNM1 homolog (22, 23) that shows a 4- to-5-fold increase in
nuclear foci after exposure to irradiation or DNA crosslinking
agents and colocalizes with the p53-binding protein 53BP1
before and after irradiation and with hMre11 after irradiation,
suggesting it is recruited to repair foci (23). Patients with
mutations in the Snm1 homology domain of Artemis (SNM1C)
show hypersensitivity to ionizing radiation and V(D)J recombi-
nation defects (5, 24). Our finding that hPso4 is essential for the
optimal repair of DSBs further underscores the importance of
this group of proteins in mammalian cells and will lead to further
studies to define the molecular mechanisms by which they act at
DNA ends.
Under stringent conditions, TdT stably associates with hPso4
through its BRCT domain in several cell lines. The BRCT domain
is also present in the NHEJ proteins pol  and Xrcc4 that assemble
Fig. 5. Time course of hPso4 induction in response to DNA damage MRC5
cells treated with 12-Gy  irradiation (A), 100 gml bleomycin (B), 100 gml
cisplatin (C), 50 gml mitomycin C (D), and 15 Jm2 UV (E). Western blots
containing 30 g of cell extracts prepared from untreated or treated (0.5–6 h)
cells were probed with anti-hPso4, antiphosphoserine15-p53 (P-serine 15), or
anti-Ku86 antibodies, as indicated.
Fig. 6. Effect of siRNA transfection on hPso4 expression. (A) MRC5 cells were
transfected with control or hPso4 siRNA. Twenty-four hours posttransfection,
cells were -irradiated at 12 Gy. Western blots containing 75 g of cell extracts
prepared from nonirradiated or irradiated (1–4 h) cells were probed with anti-
hPso4 or anti-Ku86 antibodies, as indicated. (B) Western analysis of whole cell
extracts prepared from HeLa cells (1.5  106) transfected with either the control
siRNA (lanes 2 and 5) or the hPso4-siRNA (lanes 3 and 6) and probed with
anti-hPso4 or anti-Ku 86 antibodies. (C) Flow cytometry of control and hPso4
siRNA transfected cells unirradiated (Upper) or -irradiated at 15 Gy (Lower),
incubated in fresh growth medium to allow repair, and fixed after 3 h. Cells were
stained with anti-BrdUrd-FITC to detect DSBs at which Br-dUTP had been
incorporated by using TdT (14, 19). Similar results were obtained in a second
experiment.
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as multiprotein complexes at DNA ends to assist in end joining (25)
and in the DSBR protein Nbs1 that binds -H2AX through its
fork-head associatedBRCT domain. This domain is also necessary
for the formation of hMRE11RAD50Nbs1 foci and cell survival
after irradiation (26). The interaction of hPso4 with TdT through
the BRCT domain suggests that hPso4 may be recruited to repair
sites through protein–protein interactions and perhaps in turn
stabilizes the repair complexes assembled at these sites by way of its
WD-40 repeats, which are known to have a scaffolding role. Future
studies will determine whether these repeats are important for the
function of hPso4 in DSBR.
We thank Dr. Will Burkhart and Kevin Blackburn at Burroughs Well-
come for protein sequencing, Nancy Martin for FACS analysis, and Dr.
Peter Groenen for hCdc5 antibodies. We also thank Drs. Nupam
Mahajan, Josef Spychala, and Dale Ramsden for critical reading of the
manuscript and Dr. David Sorscher for suggestions. K.N.M is a recipient
of the Ruth Kirschtein Post Doctoral award. This work was supported by
Public Health Service Grant RO1 CA34085 (to B.S.M.).
1. Jackson, S. P. (2002) Carcinogenesis 23, 687–696.
2. D’Andrea, A. D. & Grompe, M. (2003) Nat. Rev. Cancer 1, 23–34.
3. Gellert, M. (2002) Annu. Rev. Biochem. 71, 101–132.
4. Dai, Y., Kysela, B., Hanakahi, L. A., Manolis, K., Riballo, E., Stumm, M., Harville, T. O., West,
S. C., Oettinger, M. A. & Jeggo, P. (2003) Proc. Natl. Acad. Sci. USA 5, 2462–2467.
5. Li, L., Moshous, D., Zhou, Y., Wang, J., Xie, G., Salido, E., Hu, D., de Villartay, J. P. & Cowan,
M. J. (2002) J. Immunol. 168, 6323–6329.
6. Ma, Y., Pannicke, U., Schwarz, K. & Lieber, M. R. (2002) Cell 108, 781–794.
7. Benedict, C. L., Gilfillan, S., Thai, T. H. & Kearney, J. F. (2000) Immunol. Rev. 175, 150–157.
8. Mahajan, K. N., Gangi-Peterson, L., Sorscher, D. H., Wang, J., Gathy, K. N., Mahajan, N. P.,
Reeves, W. H. & Mitchell, B. S. (1999) Proc. Natl. Acad. Sci. USA 96, 13926–13931.
9. Bogue, M. A., Wang, C., Zhu, C. & Roth, D. B. (1997) Immunity 7, 37–47.
10. Purugganan, M. M., Shah, S., Kearney, J. F. & Roth, D. B. (2001) Nucleic Acids Res. 29,
1638–1646.
11. Bradbury, J. M. & Jackson, S. P. (2003) Biochem. Soc. Trans. 31, 40–44.
12. Pandey, V. N., Dave, V. P., Patil, M. S., Pradhan, D. S., Amrute, S. B. & Modak, M. J. (1990)
Biochemistry 29, 4037–4041.
13. Grey, M., Dusterhoft, A., Henriques, J. A. & Brendel, M. (1996) Nucleic Acids Res. 24,
4009–4014.
14. Li, X. & Darzynkiewicz, Z. (1995) Cell Prolif. 28, 571–579.
15. Ulrich, H. D. (2003) J. Biol. Chem. 278, 7051–7058.
16. Gerner, C., Holzmann, K., Meissner, M., Gotzmann, J., Grimm, R. & Sauermann, G. (1999)
J. Cell Biochem. 74, 145–151.
17. Bernstein, H. S. & Coughlin, S. R. (1997) J. Biol. Chem. 272, 5833–5837.
18. de Morais, M. A., Jr., Vicente, E. J., Brozmanova, J., Schenberg, A. C. & Henriques, J. A. (1996)
Curr. Genet. 29, 211–218.
19. Kodym, R. & Horth, E. (1995) Int. J. Radiat. Biol. 68, 133–139.
20. Bredel, M. & Henriques, J. A. (2001) Mutat. Res. 489, 79–96.
21. Magana-Schwencke, N., Henriques, J. A., Chanet, R. & Moustacchi, E. (1982) Proc. Natl. Acad.
Sci. USA 79, 1722–1726.
22. Dronkert, M. L., de Wit, J., Boeve, M., Vasconcelos, M. L., van Steeg, H., Tan, T. L.,
Hoeijmakersm, J. H. & Kanaar, R. (2000) Mol. Cell. Biol. 20, 4553–4561.
23. Richie, C. T., Peterson, C., Lu, T., Hittelman, W. N., Carpenter, P. B. & Legerski, R. J. (2002)
Mol. Cell. Biol. 20, 8635–8647.
24. Noordzij, J. G., Verkaik, N. S., van der Burg, M., van Veelen, L. R., de Bruin-Versteeg, S.,
Wiegant, W., Vossen, J. M., Weemaes, C. M., de Groot, R., Zdzienicka, M. Z., et al. (2003) Blood
101, 1446–1452.
25. Mahajan, K. N., Nick McElhinny, S. A., Mitchell, B. S. & Ramsden, D. A. (2002) Mol. Cell. Biol.
14, 5194–5202.
26. Zhao, S., Renthal, W. & Lee, E. Y. (2002) Nucleic Acids Res. 30, 4815–4822.
Fig. 7. Effect of hPso4 on cell survival after DNA damage. Cell death ELISAs were performed on 105 HeLa cells or cells transfected with the control or hPso4 siRNAs
and treated with etoposide (A) or mitomycin C (B) for 1 h. Each graph is the result of three independent transfections assayed in duplicate and represents the mean 
SEM. Clonogenic survival assays were performed on 105 HeLa parental cells or cells transfected with the control or hPso4 siRNAs and exposed to indicated doses of 
irradiation.Cellsweretrypsinizedandthenplatedatadensityof200cellsper100-mm-diameterdish.Survivingcolonieswerecountedafter12days. (C)Arepresentative
clonogenic survival assay. (D) Survival data from three independent transfections assayed in triplicate. Data are shown as percent of control and represent the mean 
SEM.
Mahajan and Mitchell PNAS  September 16, 2003  vol. 100  no. 19  10751
CE
LL
BI
O
LO
G
Y
